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Celiac disease (CD) or gluten sensitive enteropathy is an immune-mediated disease in genetically susceptible individuals to gluten containing foods such as wheat, 
rye, barley, and oats. It is a known inflammatory disorder with 
a prevalence of 1-2% [1]. Intestinal biopsy is the ideal way 
to assess dietary compliance but is not feasible in most of the 
cases [2]. Search is on for an ideal biomarker, which is easily 
available and cost-effective. Tissue transglutaminase antibody 
(TTGA) and anti-endomysial antibody (EMA) have been used 
traditionally [3-5]. Limitations are high cost and lack of easy 
availability of TTGA as well as EMA in peripheral health centers. 
Besides in some cases with very high TTGA levels on initial 
diagnosis, there is delayed return to base line levels limiting its 
value as a biomarker for short-term follow-up.
Mean platelet volume (MPV) has recently been recognized 
as an inflammatory marker in various conditions including 
ulcerative colitis, acute pancreatitis, and myocardial infarction. 
Investigators have reported an association between increased 
MPV and disease severity [6-9]. The relationship between MPV 
and CD was first reported by O’Grady et al. [10]. Considering 
the inflammatory nature of the disease, we aimed to assess 
MPV as a biomarker for short-term follow-up as it is easily 
available from coulters placed even in primary care setups. We 
intended to compare it with traditional TTG assay in Indian 
children, for monitoring dietary compliance of gluten-free 
diet (GFD) in CD and to assess correlation between these two 
biomarkers.
MATERIAL AND METHODS
This observational study was conducted in a tertiary level hospital 
in North India from March 2013 to December 2014. Children aged 
<12 years who were diagnosed as CD on the basis of positive 
TTG and confirmed by intestinal biopsy based on modified Marsh 
classification were enrolled after informed parental consent and 
assent wherever applicable. The study was approved by the 
institutional review board. Children with pre-existing chronic 
pulmonary disease, ankylosing spondylitis, rheumatoid arthritis, 
ulcerative colitis, renal disease, cyanotic congenital heart disease, 
or acute or chronic infections, which could have altered the MPV, 
were excluded from the study [6-9].
Thirty-five consecutively presenting newly diagnosed 
children with CD were enrolled. Sample size was calculated based 
on a previous study demonstrating a mean difference of 0.4 fl in 
MPV before, and after GFD with alpha error of 5%, power of 
80%, and with attrition of 20%, a total of 33 as a sample size was 
obtained [11]. Children were started on GFD and were followed 
up at 3 monthly intervals. The clinical parameters such as gain 
in weight and height, laboratory parameters such as TTG assay 
and MPV were measured at these time points. This period was 
selected based on a previous study at which changes were evident 
and attrition in the study group was unlikely.
MPV was measured at the time of enrollment using Sysmex 
automated cell counter by taking 1 ml of blood in ethylenediamine 
tetraacetic acid. Analysis was done within 2 h of blood sample 
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collection. The coulter principle is based on volumetric analysis. 
The cells in suspension pass through a small aperture between 
two chambers in which there is an electrical current. As each 
cell passes, it creates an impulse, which is considered to be 
proportional to the volume of the cell detected between the two 
electrodes. The normal reference range of MPV is 7.61 fl-10.19 fl 
with no significant differences for age [12]. TTG levels were 
done using DRG TTG-A enzyme-linked immunosorbent assay 
(ELISA) REF EIA-10503 kit. TTG antibody testing was done 
using sandwich ELISA (Euroimmune, Luebeck, Germany). The 
sensitivity of the assay was 0.26 U/ml. A simultaneous assay of 
the total IgA was done in all cases to exclude the possibility of 
missing a potential case with low IgA levels.
Patients with positive serology underwent 4-forked duodenal 
biopsy to confirm the diagnosis. A single observer did the 
histopathology grading on all the tissue specimens. Biopsy 
specimens comprising of at least four fragments with a forceps 
(open cup ~ 6 mm) were taken. Samples were carefully oriented 
on filter paper and fixed in 10% formalin. Histopathology 
was expressed according to the Marsh classification. A single 
pathologist who read all the biopsy specimens was blinded to 
the results obtained on serological testing. The study participants 
were followed up, and dietary adherence was indirectly assessed 
by the improvement in symptoms and gain in weight and height 
and observation of the diary maintained by them. Counseling was 
done at each visit to ensure compliance by a dedicated nutritionist.
All statistical tests were performed using the Statistical 
Package for Social Sciences Version 16. All data were given as 
mean values and standard deviation. Paired-t-test was used to 
analyze pre- and post-values for normal distribution and Wilcoxon 
sign rank test was used for non-normal distribution. Chi-square 
test was used for comparison of categorical variables. The p<0.05 
was considered significant. Correlation coefficient was calculated 
to ascertain the relation between the two biomarkers.
RESULTS
Out of 35 children enrolled to the study, 32 completed the study. 
Six children were <3 years, 9 between 3 and 6 years, 11 between 
6 and 9 years, and 9 between 9 and 12 years. 45% were males. 
Clinical presentation of the children is shown in Table 1.
33 (94.3%) children were anemic. Short stature was also found 
in 33 (94.3%) children. Weight of 27 (77.1%) children was less 
than −3SD for corresponding age and sex. Histologically, lesions 
of Marsh 3a was present in 1 child, whereas 3b in 20 (57.1%) 
children and 3c in 14 (40%) children.
The mean baseline MPV value at enrollment was 9.28±1.88 fL. 
Mean baseline MPV values for those cases had histopathology of 
Marsh 3c, 3b, and 3a are 9.03±0.99, 9.45±1.17, and 9.3±0.83, 
respectively. There was no significant difference in mean baseline 
MPV titers between different Marsh classes (p=0.56). MPV 
reduced significantly to 8.55±1.10 fl after GFD (p<0.001). Fig. 1 
demonstrates the change in MPV at 3 months of institution of 
GFD. The mean TTG level of the total study population was 
166.80±59.23 U/ml. There was statistically significant difference 
(p=0.047) in mean baseline titers of TTG levels between different 
Marsh classes. The mean TTG levels were 86.45±39.67 U/ml 
after 3 months of GFD (p<0.001).
Pre- and post-GFD values of MPV had a good correlation of 
r=0.75. Pre- and post-GFD values of TTG had a good correlation 
of r=0.50 (p=0.022). The correlation between the values of TTG 
and MPV both pre- and post-intervention did not correlate well 
with pre r=0.05 and post r=0.02.
DISCUSSION
This hospital-based observational study showed a statistically 
significant decline in MPV and TTGA in patients on GFD which 
could be used as a monitoring tool to assess dietary compliance 
in CD patients. The mean baseline MPV reduced significantly 
(9.28±1.88 fl-8.55±1.10 fl, (p<0.001) after 3 months of GFD. 
Purnak et al., in a similarly designed study, evaluated 60 newly 
diagnosed CD patients and 40 healthy controls and observed that in 
the compliant group, 3 months after initiation of GFD, a significant 
decrease in MPV from base-line values was seen, (8.56 fl-8.2 fl; 
p=0.008) [11]. The difference in MPV values could be due 
to difference in the type of counter used. In the same cohort of 
patients, after 3 months of GFD, the mean value of TTGA reduced 
significantly (p<0.01). The time period to complete normalization 
of TTG titers is longer and could be even up to 2 years. The fall in 
antibody titers along with clinical improvement suggested dietary 
compliance. This result was consistent with previous studies [13]. 
Table 1: Clinical presentation of study population
Feature Frequency (%)
Short stature 33 (94.3)
Diarrhea 28 (80.0)
Abdominal distension 15 (42.9)




Figure 1: Box plot depicting baseline mean platelet volume (MPV) 
values and MPV values after gluten free diet
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As MPV is a marker of inflammation it rapidly changes when 
inflammation subsides, whereas TTGA being an immune marker 
takes longer to reach baseline levels.
The mean TTG level of the study population 
(166.80±59.23 U/ml) was comparable with the study conducted by 
Rawal et al. (164.24 U/ml) [14]. Tursi et al. showed that the mean 
serum value of anti-TTG ranged from 3.6 U/ml in Marsh 1 lesions 
to 74.95 U/ml in Marsh 3c lesions, respectively; however, the values 
were not comparable owing to different cutoffs and different kits 
used in the study [15]. It was observed that the mean TTG levels 
also varied among different Marsh classes. The difference was 
statistically significant (p=0.047). This is supported by various 
previous studies depicting higher TTGA levels with a higher Marsh 
score [15]. The difference in TTGA values in different Marsh classes 
was explained by the severity of inflammation in different classes.
Correlation coefficient for MPV and TTG showed good 
significance individually but on comparison of both correlation 
coefficients did not correlate well. This could be due to smaller 
sample size as sample size was calculated to assess fall in MPV 
after 3 months GFD in CD. This could also be because fall in 
TTG occurs slowly over a span of 2 years in children on GFD. It 
is also plausible that the grade of inflammation may not correlate 
with the enterocyte loss. Follow-up of antibody titers has been 
proposed as a good indicator of transgressions in CD patients. 
However, there are some limitations in routine clinical practice 
with TTGA. Some patients may have extremely high base-line 
antibody titers on initial diagnosis, and a delayed return to normal 
levels in such cases may mislead clinicians.
MPV is one of the biomarkers that has been sparingly used to 
monitor CD. O’Grady et al. first reported the relationship between 
MPV and CD. They compared the MPV values of three groups 
(CD patients, normal controls, and splenectomised patients). The 
authors discovered that CD patients with intact spleens had higher 
MPV values and platelet counts [10]. This is understandable as 
platelet size is regulated at the level of megakaryocytes and is 
influenced by IL-3 and IL-6 levels. This leads to production of 
more reactive and large platelets [16]. However, these investigators 
did not evaluate the effect of a gluten-free diet on MPV.
The limitation of MPV would be its fallacy to detect adherence 
to GFD in the face of any cause for acute inflammation like a 
concomitant gastrointestinal illness or acute diarrhea. If this were 
to be excluded, this marker appears to be promising for short-
term follow-up. However, initially it does not correlate well with 
grade of enterocyte loss; hence, can only be used for follow-up. 
Different analyzer devices might produce different MPV results 
leading to difficulty in the generalization of results. Hence, one 
needs to establish their own cutoffs in their setting. The study 
sample size was small and the follow-up in this study with MPV 
was done for only 3 months. Following these, children further 
could have helped us evaluate its utility in the longterm. Using 
a control group not on GFD would have substantiated our 
hypothesis further but was not ethically feasible.
CONCLUSION
MPV could be useful for short-term follow-up when compared to 
other available biomarkers due to its low cost, easy availability 
even in primary health centers and requirement of low blood 
volumes, a very important aspect in pediatric patients in following 
in these patients short term.
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